Search form

We are committed to improving patients' lives.

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Since its founding in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.

Cancer Immunology

Cancer Immunology at Boehringer Ingelheim

Scientists at Boehringer Ingelheim are exploring exciting new approaches to turn up the heat on cancer by firing up our immune systems in a tumor-specific manner.

Biosimilars are an exciting new development in the field of biologic medicines. We have a rich history of manufacturing biologics, and are proud to leverage our expertise to develop biosimilar drug candidates for autoimmune diseases and cancer.